SM
GILD icon

Scoggin Management’s Gilead Sciences GILD Stock Holding History

Scoggin Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-52,000
Closed -$4.9M – 114
2014
Q4 		$4.9M Buy
+52,000
New +$5.38M 0.44% 40

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Scoggin Management's GILD Position: Q1 2015 in Review

Scoggin Management sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 52,000 shares — an estimated $4.9M sold.

Scoggin Management first reported a position in GILD in Q4 2014 and held it in 1 quarter. The position peaked at $4.9M in Q4 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Scoggin Management reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Scoggin Management sold 52,000 Gilead Sciences shares in Q1 2015, an estimated $4.9M.
  • Scoggin Management first reported a position in Gilead Sciences in Q4 2014 and held it in 1 quarter.
  • Scoggin Management's Gilead Sciences position peaked at $4.9M in Q4 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Scoggin Management's 13F filing for Q1 2015, filed 15 May 2015.